Breaking News

Unemployment Insurance Weekly Claims Report Agents Encounter and Seize Cloned Border Patrol Vehicle Attempting Illegal Entry USAID Announces Expansion in the Pacific Region and Reaffirms Commitment to Bolster Resilience in the Pacific Islands at the 2022 U.S.-Pacific Island Country Summit | Press Release Governor Abbott Deploys Additional Resources To Florida To Assist Hurricane Ian Response Efforts | Office of the Texas Governor Flag Officer Assignments > U.S. Department of Defense > Release USCIS Awards FY 2022 Citizenship and Integration Grants Governor Newsom Deploys Emergency Personnel to Florida to Aid With Response to Hurricane Ian VMWare Releases Guidance for VirtualPITA, VirtualPIE, and VirtualGATE Malware Targeting vSphere

Humberto Antunes, Nestlé Skin Health CEO, has decided to give a new direction to his career and will leave Nestlé at the end of October 2016. Humberto Antunes joined Galderma in 1997, took over the leadership of Galderma’s worldwide operations in 2004 and finally became Nestlé Skin Health CEO in 2014. During this period the company became a global player in dermatology. Nestlé thanks Humberto Antunes for his contribution and wishes him every success in his new activities.

Paul Navarre is joining Nestlé and will take over from Humberto Antunes as Nestlé Skin Health CEO on 1 November 2016. Paul Navarre is a French national with an MBA from the ISC Paris Business School who started his career with Procter & Gamble where he spent 15 years in different countries and positions involving both consumer goods and healthcare. He then joined Allergan, a global pharmaceutical company, in 2007 where, after various leadership roles over a period of 10 years, he most recently was President of Allergan International.

Paul Navarre’s consumer goods and healthcare background, his extensive international career and proven leadership skills make him ideally suited to take Nestlé Skin Health to the next level by further pursuing its strategy covering consumer solutions and self-medication, prescription as well as aesthetic and corrective products.


Media: Robin Tickle Tel.: +41 21 924 22 00
Investors: Steffen Kindler Tel.: +41 21 924 35 09

PDF press releases:


Source link